BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 34837015)

  • 1. O-GlcNAcylation in health and neurodegenerative diseases.
    Lee BE; Suh PG; Kim JI
    Exp Mol Med; 2021 Nov; 53(11):1674-1682. PubMed ID: 34837015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.
    Thompson JW; Sorum AW; Hsieh-Wilson LC
    Biochemistry; 2018 Jul; 57(27):4010-4018. PubMed ID: 29936833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
    Butkinaree C; Park K; Hart GW
    Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus.
    Stewart LT; Khan AU; Wang K; Pizarro D; Pati S; Buckingham SC; Olsen ML; Chatham JC; McMahon LL
    J Neurosci; 2017 Aug; 37(34):8207-8215. PubMed ID: 28760863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.
    Ryan P; Xu M; Davey AK; Danon JJ; Mellick GD; Kassiou M; Rudrawar S
    ACS Chem Neurosci; 2019 May; 10(5):2209-2221. PubMed ID: 30985105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc cycling: implications for neurodegenerative disorders.
    Lazarus BD; Love DC; Hanover JA
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2134-46. PubMed ID: 19782947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
    Park J; Lai MKP; Arumugam TV; Jo DG
    Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.
    Zhang S; Roche K; Nasheuer HP; Lowndes NF
    J Biol Chem; 2011 Oct; 286(43):37483-95. PubMed ID: 21896475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
    Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation.
    Thompson JW; Griffin ME; Hsieh-Wilson LC
    Methods Enzymol; 2018; 598():101-135. PubMed ID: 29306432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation and cardiovascular disease.
    Wright JN; Collins HE; Wende AR; Chatham JC
    Biochem Soc Trans; 2017 Apr; 45(2):545-553. PubMed ID: 28408494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
    Chun YS; Kwon OH; Chung S
    Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    Du P; Zhang X; Lian X; Hölscher C; Xue G
    J Alzheimers Dis; 2024; 97(3):1051-1068. PubMed ID: 38250776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of O-GlcNAc in chronic diseases of aging.
    Banerjee PS; Lagerlöf O; Hart GW
    Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. dbOGAP - an integrated bioinformatics resource for protein O-GlcNAcylation.
    Wang J; Torii M; Liu H; Hart GW; Hu ZZ
    BMC Bioinformatics; 2011 Apr; 12():91. PubMed ID: 21466708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of synaptic transmission through O-GlcNAcylation.
    Han S; Kim JN; Park CH; Byun JS; Kim DY; Ko HG
    Mol Brain; 2024 Jan; 17(1):1. PubMed ID: 38167470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of mitochondrial network homeostasis by O-GlcNAcylation.
    Xue Q; Yan R; Ji S; Yu S
    Mitochondrion; 2022 Jul; 65():45-55. PubMed ID: 35513218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.